Global Oral Proteins & Peptides Market

Global Oral Proteins & Peptides Market by Player, Region, Type, Application and Sales Channel

Global Oral Proteins & Peptides Market

Global Oral Proteins & Peptides Market by Player, Region, Type, Application and Sales Channel


The Oral Proteins & Peptides study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

The global Oral Proteins & Peptides market size is estimated to be $6.84 billion in 2024, and Market IntelliX analysts predict it will reach $21.9 billion by 2033, growing at a CAGR of 13.8% during the forecast period from 2025 to 2033.

The evolving U.S. tariff policy in 2025 is bringing considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the world, assessing their impacts on Oral Proteins & Peptides market competitiveness, regional economic interdependencies, and supply chain reconfigurations.

Oral proteins and peptides are biologically active molecules administered via capsules, tablets, or liquids to treat various diseases. These molecules are fundamental to living organisms, participating in essential biological processes such as enzyme activity, immune responses, and cellular signaling.

The major players in the global Oral Proteins & Peptides market include Novo Nordisk (Denmark), AbbVie (US), Pfizer (US), Acadia Pharmaceuticals (US), Aurinia Pharmaceuticals (Canada), Bausch Health (Canada), CHIESI Farmaceutici (Italy), EnteraBio (Israel), Merck (US), Johnson & Johnson (US), etc. In 2024, the global top 5 players together accounted for approximately xx% market share in terms of revenue.

Market Drivers & Opportunities:

Rising prevalence of chronic diseases.

Robust clinical trial pipeline for oral proteins and peptides.

Market Restraints & Challenges:

High cost associated with drug development.

Challenges from maintaining formulations and stability.

North America Oral Proteins & Peptides market size is estimated to increase from $xx million in 2024 to $xx million by 2033, growing at a CAGR of xx% during the forecast period of 2025 through 2033.

China Oral Proteins & Peptides market size is estimated to increase from $xx million in 2024 to $xx million by 2033, growing at a CAGR of xx% during the forecast period of 2025 through 2033.

Europe Oral Proteins & Peptides market size is estimated to increase from $xx million in 2024 to $xx million by 2033, growing at a CAGR of xx% during the forecast period of 2025 through 2033.

Leading Players of Oral Proteins & Peptides include:

Novo Nordisk (Denmark)

AbbVie (US)

Pfizer (US)

Acadia Pharmaceuticals (US)

Aurinia Pharmaceuticals (Canada)

Bausch Health (Canada)

CHIESI Farmaceutici (Italy)

EnteraBio (Israel)

Merck (US)

Johnson & Johnson (US)

R-Pharm JSC (Russia)

Proxima Concepts (US)

SWK Holdings (US)

AstraZeneca (UK)

Regor Therapeutics (China)

Market split by Type:

Linaclotide

Plecanatide

Calcitonin

Insulin

Octreotide

Others

Market split by Application:

Diabetes

CNS Disorders

Gastroenterology

Genetic Disorders

Nephrology

Obesity & Overweight

Market split by Sales Channel:

Direct Channel

Distribution Channel

Market split by Region/Country:

North America (United States and Canada)

Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia, etc.)

South America (Brazil, Mexico, and Argentina, etc.)

Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.

Chapter 1 Oral Proteins & Peptides Market Overview

1.1 Oral Proteins & Peptides Definition

1.2 Global Oral Proteins & Peptides Market Size Status and Outlook (2019-2033)

1.3 Global Oral Proteins & Peptides Market Size Comparison by Region (2019-2033)

1.4 Global Oral Proteins & Peptides Market Size Comparison by Type (2019-2033)

1.5 Global Oral Proteins & Peptides Market Size Comparison by Application (2019-2033)

1.6 Global Oral Proteins & Peptides Market Size Comparison by Sales Channel (2019-2033)

1.7 Oral Proteins & Peptides Market Dynamics (2025 US Tariffs Impacts)

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Restraints

1.7.3 Market News (Merger/Acquisition/Expansion)

1.7.4 Market Trends & Development

1.7.5 2025 US Tariffs Policy Impacts

Chapter 2 Oral Proteins & Peptides Market Competition by Player

2.1 Global Oral Proteins & Peptides Sales and Market Share by Player (2022-2024)

2.2 Global Oral Proteins & Peptides Revenue and Market Share by Player (2022-2024)

2.3 Global Oral Proteins & Peptides Average Price by Player (2022-2024)

2.4 Players Competition Situation & Trends

2.5 Conclusion of Competition by Player

Chapter 3 Oral Proteins & Peptides Market Segment by Type

3.1 Global Oral Proteins & Peptides Market by Type

3.1.1 Linaclotide

3.1.2 Plecanatide

3.1.3 Calcitonin

3.1.4 Insulin

3.1.5 Octreotide

3.2 Global Oral Proteins & Peptides Sales and Market Share by Type (2019-2024)

3.3 Global Oral Proteins & Peptides Revenue and Market Share by Type (2019-2024)

3.4 Global Oral Proteins & Peptides Average Price by Type (2019-2024)

3.5 Conclusion of Segment by Type

Chapter 4 Oral Proteins & Peptides Market Segment by Application

4.1 Global Oral Proteins & Peptides Market by Application

4.1.1 Diabetes

4.1.2 CNS Disorders

4.1.3 Gastroenterology

4.1.4 Genetic Disorders

4.1.5 Nephrology

4.2 Global Oral Proteins & Peptides Revenue and Market Share by Application (2019-2024)

4.3 Conclusion of Segment by Application

Chapter 5 Oral Proteins & Peptides Market Segment by Sales Channel

5.1 Global Oral Proteins & Peptides Market by Sales Channel

5.1.1 Direct Channel

5.1.2 Distribution Channel

5.2 Global Oral Proteins & Peptides Revenue and Market Share by Sales Channel (2019-2024)

5.3 Conclusion of Segment by Sales Channel

Chapter 6 Oral Proteins & Peptides Market Segment by Region & Country

6.1 Global Oral Proteins & Peptides Market Size and CAGR by Region

6.2 Global Oral Proteins & Peptides Sales and Market Share by Region (2019-2024)

6.3 Global Oral Proteins & Peptides Revenue and Market Share by Region (2019-2024)

6.4 North America

6.4.1 North America Market by Country

6.4.2 North America Oral Proteins & Peptides Market Share by Type

6.4.3 North America Oral Proteins & Peptides Market Share by Application

6.4.4 United States

6.4.5 Canada

6.5 Europe

6.5.1 Europe Market by Country

6.5.2 Europe Oral Proteins & Peptides Market Share by Type

6.5.3 Europe Oral Proteins & Peptides Market Share by Application

6.5.4 Germany

6.5.5 UK

6.5.6 France

6.5.7 Italy

6.5.8 Spain

6.5.9 Russia

6.6 Asia-Pacific

6.6.1 Asia-Pacific Market by Country

6.6.2 Asia-Pacific Oral Proteins & Peptides Market Share by Type

6.6.3 Asia-Pacific Oral Proteins & Peptides Market Share by Application

6.6.4 China

6.6.5 Japan

6.6.6 Korea

6.6.7 India

6.6.8 Southeast Asia

6.6.9 Australia

6.7 South America

6.7.1 South America Market by Country

6.7.2 South America Oral Proteins & Peptides Market Share by Type

6.7.3 South America Oral Proteins & Peptides Market Share by Application

6.7.4 Brazil

6.7.5 Mexico

6.7.6 Argentina

6.7.7 Colombia

6.8 Middle East & Africa

6.8.1 Middle East & Africa Market by Country

6.8.2 Middle East & Africa Oral Proteins & Peptides Market Share by Type

6.8.3 Middle East & Africa Oral Proteins & Peptides Market Share by Application

6.8.4 Turkey

6.8.5 UAE

6.8.6 Saudi Arabia

6.8.7 South Africa

6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Oral Proteins & Peptides Players

7.1 Novo Nordisk (Denmark)

7.1.1 Company Snapshot

7.1.2 Product/Service Offered

7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

7.1.4 Company News & Recent Development

7.1.5 Company SWOT Analysis

7.3 Pfizer (US)

7.4 Acadia Pharmaceuticals (US)

7.5 Aurinia Pharmaceuticals (Canada)

7.6 Bausch Health (Canada)

7.7 CHIESI Farmaceutici (Italy)

7.8 EnteraBio (Israel)

7.9 Merck (US)

7.10 Johnson & Johnson (US)

7.11 R-Pharm JSC (Russia)

7.12 Proxima Concepts (US)

7.13 SWK Holdings (US)

7.14 AstraZeneca (UK)

7.15 Regor Therapeutics (China)

Chapter 8 Upstream and Downstream Analysis of Oral Proteins & Peptides

8.1 Industrial Value Chain of Oral Proteins & Peptides

8.2 Upstream of Oral Proteins & Peptides

8.3 Downstream of Oral Proteins & Peptides

Chapter 9 Global Oral Proteins & Peptides Market Forecast (2025-2033)

9.1 Global Oral Proteins & Peptides Market Size (Sales and Revenue) Forecast (2025-2033)

9.2 Global Oral Proteins & Peptides Market Size and CAGR Forecast by Region (2025-2033)

9.3 Global Oral Proteins & Peptides Market Size and CAGR Forecast by Type (2025-2033)

9.4 Global Oral Proteins & Peptides Market Size and CAGR Forecast by Application (2025-2033)

9.5 Global Oral Proteins & Peptides Market Size and CAGR Forecast by Sales Channel (2025-2033)

Chapter 10 Appendix

10.1 Research Methodology

10.2 Data Sources

10.3 Disclaimer

10.4 Analysts Certification

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Oral Proteins & Peptides Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
What is the forecasted growth rate of the Oral Proteins & Peptides Market?
The Oral Proteins & Peptides Market is expected to grow at a moderate CAGR during the forecast period of 2025 to 2030.
What trends may have an impact on the Oral Proteins & Peptides Market's growth?
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the Oral Proteins & Peptides Market as well as its distribution among its players
What is the CAGR at which the Oral Proteins & Peptides Market can expand?
During the forecast years, the Oral Proteins & Peptides Market can thrive with a robust CAGR.